OECD Principles of Corporate Governance
The G20/OECD Principles — the global reference point for corporate governance policy, used by regulators and investors worldwide.
Visit sourceLibrary
— an old proverb, quoted by Anton Chekhov
The G20/OECD Principles — the global reference point for corporate governance policy, used by regulators and investors worldwide.
Visit sourceThe UK's 'comply or explain' code for premium-listed companies, maintained by the Financial Reporting Council.
Visit sourceInvestor-led global network setting standards on governance and stewardship across markets.
Visit sourceUS membership body for directors, with research, benchmarking and practical board-practice guidance.
Visit sourceUK professional body for directors, including its Code of Conduct for Directors and chartered director qualification.
Visit sourceHigh-volume scholarly and practitioner commentary on governance, boards, M&A, activism and securities law.
Visit sourceAnnual benchmarking of board composition, structure and practice across major markets.
Visit sourceUniversity of Oxford's business school, with executive programmes on board effectiveness, governance and sustainable corporations.
Visit sourceNorthwestern Kellogg's director and corporate governance executive programme for current and prospective board members.
Visit sourceWharton (University of Pennsylvania) board leadership and corporate governance executive education.
Visit sourceThe OECD's AI policy observatory and the OECD AI Principles — a reference point for trustworthy AI.
Visit sourceThe US framework for identifying and managing AI risk, increasingly used as a board-level reference.
Visit sourceThe European Commission's regulatory framework for AI, including the EU AI Act and its risk-based obligations.
Visit sourceStanford's institute on human-centred AI, publisher of the widely cited annual AI Index report.
Visit sourceUK research institute on data and AI in the public interest, with rigorous policy and ethics work.
Visit sourceThe US regulator for medical devices, software as a medical device and digital health.
Visit sourceThe UK's medicines and medical-devices regulator, including its software and AI-as-a-medical-device work.
Visit sourceUK body assessing clinical and cost-effectiveness — central to reimbursement and adoption decisions.
Visit sourceThe European trade association for medical technology, tracking regulation, MDR and market access.
Visit sourceGovernance, audit, strategy, risk and succession insights for directors, plus director education programmes.
Visit sourceBoard composition, risk oversight and ESG, anchored by PwC's Annual Corporate Directors Survey.
Visit sourceBoard priorities, effectiveness frameworks and governance data drawn from 1,700+ public companies.
Visit sourceStrategy, risk, talent, sustainability, data governance and AI for boards, with director programmes and tools.
Visit sourceMcKinsey's collection on board composition, processes, strategy and the value of effective governance.
Visit sourceBain's perspective on how boards should sharpen their agenda, composition and effectiveness.
Visit sourceMcKinsey's AI arm: enterprise AI strategy, gen-AI value creation and deployment insights.
Visit sourceScaling AI across the enterprise, the annual AI Radar survey and the CEO/board agenda for AI.
Visit sourceApplied AI research and eminence across industries, with a focus on enterprise adoption and trust.
Visit sourceEnterprise AI adoption trends, governance frameworks and KPMG's quarterly AI Pulse survey.
Visit sourceAI strategy, risk, trust and transformation, anchored by the EY.ai platform and adoption surveys.
Visit sourceAI adoption, ROI and operating-model research, including Bain's generative-AI surveys.
Visit source